Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain

Cancer pain remains a major challenge and there is an urgent demand for the development of specific mechanism-based therapies. Various diseases are associated with unique signatures of expression of microRNAs (miRNAs), which reveal deep insights into disease pathology. Using a comprehensive approach...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bali, Kiran Kumar (VerfasserIn) , Selvaraj, Deepitha (VerfasserIn) , Satagopam, Venkata* (VerfasserIn) , Lu, Jianning (VerfasserIn) , Schneider, Reinhard (VerfasserIn) , Kuner, Rohini (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 October 2013
In: EMBO molecular medicine
Year: 2013, Jahrgang: 5, Heft: 11, Pages: 1740-1758
ISSN:1757-4684
DOI:10.1002/emmm.201302797
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/emmm.201302797
Verlag, lizenzpflichtig, Volltext: https://www.embopress.org/doi/full/10.1002/emmm.201302797
Volltext
Verfasserangaben:Kiran Kumar Bali, Deepitha Selvaraj, Venkata P. Satagopam, Jianning Lu, Reinhard Schneider, Rohini Kuner
Beschreibung
Zusammenfassung:Cancer pain remains a major challenge and there is an urgent demand for the development of specific mechanism-based therapies. Various diseases are associated with unique signatures of expression of microRNAs (miRNAs), which reveal deep insights into disease pathology. Using a comprehensive approach combining genome-wide miRNA screening, molecular and in silico analyses with behavioural approaches in a clinically relevant model of metastatic bone-cancer pain in mice, we now show that tumour-induced conditions are associated with a marked dysregulation of 57 miRNAs in sensory neurons corresponding to tumour-affected areas. By establishing protocols for interference with disease-induced miRNA dysregulation in peripheral sensory neurons in vivo, we functionally validate six dysregulated miRNAs as significant modulators of tumour-associated hypersensitivity. In silico analyses revealed that their predicted targets include key pain-related genes and we identified Clcn3, a gene encoding a chloride channel, as a key miRNA target in sensory neurons, which is functionally important in tumour-induced nociceptive hypersensitivity in vivo. Our results provide new insights into endogenous gene regulatory mechanisms in cancer pain and open up attractive and viable therapeutic options.
Beschreibung:Gesehen am 13.11.2020
Beschreibung:Online Resource
ISSN:1757-4684
DOI:10.1002/emmm.201302797